coeliac disease Archives -

coeliac disease

Equillium has announced another bolt-on deal to expand its pipeline tripling the size of its clinical pipeline to

Equillium triples clinical pipeline with $329m Bioniz takeover

https://pharmaphorum.com/news/equillium-triples-clinical-pipeline-with-329m-bioniz-takeover/

Takeda has bought US biotech PvP Biologics for $330 million, adding a potential new form of therapy for

Takeda buys US biotech PvP Biologics for $330 million

https://pharmaphorum.com/news/takeda-buys-us-biotech-pvp-biologics-for-330-million/

Takeda has bought a licence for a coeliac disease drug from COUR Pharmaceuticals, after the US biotech announced

Takeda buys coeliac drug licence from COUR Pharmaceuticals

https://pharmaphorum.com/news/takeda-buys-coeliac-drug-licence-from-cour-pharmaceuticals/

GlaxoSmithKline’s longstanding collaboration with Avalon Ventures has resulted in a first deal – a buyout of Sitari Pharma

GSK buys Avalon-partnered Sitari and its coeliac drug

https://pharmaphorum.com/news/gsk-buys-avalon-partnered-sitari-and-its-coeliac-drug/

US biotech ImmusanT has been left without any R&D programmes in the clinic after pulling a coeliac disease

ImmusanT abandons coeliac disease vaccine after phase 2 flop

https://pharmaphorum.com/news/immusant-abandons-coeliac-disease-vaccine-after-phase-2-flop/

coeliac disease